Terms: = Breast cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV
23 results:
1. Pulmonary Function and Lung Fibrosis up to 12 Years After breast cancer Radiotherapy.
Karlsen J; Tandstad T; Steinshamn S; Salvesen Ø; Parlikar ND; Lundgren S; Reidunsdatter RJ
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1066-1077. PubMed ID: 38099884
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of Pneumotachometer and Portable Digital Turbine Spirometry for Field-Based Assessment: An Air Quality, Environment, and Respiratory Outcomes in Bronchopulmonary Dysplasia Study.
Mukharesh L; Ryan M; Hayden LP; Dahlberg SE; Gaffin JM
Pediatr Allergy Immunol Pulmonol; 2023 Sep; 36(3):115-118. PubMed ID: 37703537
[No Abstract] [Full Text] [Related]
3. Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.
Archangelidi O; Cullinan P; Simmonds NJ; Mentzakis E; Peckham D; Bilton D; Carr SB
J Cyst Fibros; 2022 Mar; 21(2):302-308. PubMed ID: 34348871
[TBL] [Abstract] [Full Text] [Related]
4. Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.
Revilla-López E; Berastegui C; Méndez A; Sáez-Giménez B; Ruiz de Miguel V; López-Meseguer M; Monforte V; Bravo C; Pujana MA; Ramon MA; Gómez-Ollés S; Roman A;
Sci Rep; 2021 May; 11(1):10171. PubMed ID: 33986388
[TBL] [Abstract] [Full Text] [Related]
5. Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
Groheux D; Biard L; Lehmann-Che J; Teixeira L; Bouhidel FA; Poirot B; Bertheau P; Merlet P; Espié M; Resche-Rigon M; Sotiriou C; de Cremoux P
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1279-1288. PubMed ID: 29616304
[TBL] [Abstract] [Full Text] [Related]
6. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
Garcia-Vicente AM; Molina D; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Bueno G; Tello-Galán MJ; Soriano-Castrejón Á
Ann Nucl Med; 2017 Dec; 31(10):726-735. PubMed ID: 28887761
[TBL] [Abstract] [Full Text] [Related]
7. Metabolic Tumor Burden Assessed by Dual Time Point [
Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
[TBL] [Abstract] [Full Text] [Related]
8. [Can Pulmonary Rehabilitation during Preoperative Chemoradiotherapy for Non-small Cell Lung cancer Improve the Respiratory Function?].
Tokunaga Y; Tarumi S; Yokomise H
Kyobu Geka; 2016 Jan; 69(1):47-52. PubMed ID: 26975643
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With breast cancer.
García Vicente AM; Amo-Salas M; Relea Calatayud F; Muñoz Sánchez Mdel M; Pena Pardo FJ; Jiménez Londoño GA; Álvarez Cabellos R; Espinosa Aunión R; Soriano Castrejón Á
Clin Nucl Med; 2016 Jul; 41(7):e313-22. PubMed ID: 26953659
[TBL] [Abstract] [Full Text] [Related]
10. Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.
García Vicente AM; Soriano Castrejón Á; León Martín A; Relea Calatayud F; Muñoz Sánchez Mdel M; Cruz Mora MÁ; Jiménez Londoño GA; Espinosa Aunión R
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1309-18. PubMed ID: 24744045
[TBL] [Abstract] [Full Text] [Related]
11. Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
García Vicente AM; Soriano Castrejón Á; León Martín A; Chacón López-Muñiz I; Muñoz Madero V; Muñoz Sánchez Mdel M; Palomar Muñoz A; Espinosa Aunión R; González Ageitos A
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1304-11. PubMed ID: 23632960
[TBL] [Abstract] [Full Text] [Related]
12. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
[TBL] [Abstract] [Full Text] [Related]
13. Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.
García Vicente AM; Soriano Castrejón A; Cruz Mora MA; González Ageitos A; Muñoz Sánchez Mdel M; León Martín A; Espinosa Aunión R; Relea Calatayud F; Muñoz Madero V; Chacón López-Muñiz I; Cordero García JM; Jiménez Londoño GA
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):72-9. PubMed ID: 23053321
[TBL] [Abstract] [Full Text] [Related]
14. 18F-FDG retention index and biologic prognostic parameters in breast cancer.
García Vicente AM; Castrejón ÁS; Relea Calatayud F; Muñoz AP; León Martín AA; López-Muñiz IC; Del Mar Muñoz Sánchez M; Cordero García JM; Becerra Nakayo EM
Clin Nucl Med; 2012 May; 37(5):460-6. PubMed ID: 22475895
[TBL] [Abstract] [Full Text] [Related]
15. Changes in pulmonary function up to 10 years after locoregional breast irradiation.
Erven K; Weltens C; Nackaerts K; Fieuws S; Decramer M; Lievens Y
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):701-7. PubMed ID: 21398052
[TBL] [Abstract] [Full Text] [Related]
16. Early age at menarche, lung function, and adult asthma.
Macsali F; Real FG; Plana E; Sunyer J; Anto J; Dratva J; Janson C; Jarvis D; Omenaas ER; Zemp E; Wjst M; Leynaert B; Svanes C
Am J Respir Crit Care Med; 2011 Jan; 183(1):8-14. PubMed ID: 20732985
[TBL] [Abstract] [Full Text] [Related]
17. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
[TBL] [Abstract] [Full Text] [Related]
18. tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
Wardley AM; Hiller L; Howard HC; Dunn JA; Bowman A; Coleman RE; Fernando IN; Ritchie DM; Earl HM; Poole CJ;
Br J Cancer; 2008 Aug; 99(4):597-603. PubMed ID: 18665163
[TBL] [Abstract] [Full Text] [Related]
19. Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials.
Bria E; Cuppone F; Fornier M; Nisticò C; Carlini P; Milella M; Sperduti I; Terzoli E; Cognetti F; Giannarelli D
Breast Cancer Res Treat; 2008 May; 109(2):231-9. PubMed ID: 17638068
[TBL] [Abstract] [Full Text] [Related]
20. Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment.
Schneider CM; Hsieh CC; Sprod LK; Carter SD; Hayward R
Cancer; 2007 Aug; 110(4):918-25. PubMed ID: 17582616
[TBL] [Abstract] [Full Text] [Related]
[Next]
